![]() One of the reasons why personalized treatment (Advanced CustomVue™) is preferred is that three-dimensional visual mapping can be obtained in Wavefront aberometer. This information is sent to the laser and the planned treatment is applied. The information reflected from the light sent to the eye is detected by a special camera. Now the vision can be corrected within the framework of the iLASIK application. Then, a corneal incision is made with a femtosecond without the use of a knife. In the first stage, a personal vision profile is prepared with Wavescan technology. An artificial tear drop recommended by the doctor should be used for approximately 3 – 6 months after the operation. The next day of the operation, during the check-up, If wrinkles are detected in the transparent area on the surface of the eye or if there is a reaction under the flap (valve), it may be necessary to wash the bottom of the flap. The next day of the operation, there are no side effects left that will limit social and work life. In the first days, care should be taken not to get soap and shampoo in the eyes. Avoid being in a dusty environment, the treated eye should not be rubbed, scratched, touched, washed or bathed during the first 24 hours. We do not recommend driving a car and going to work on the day of surgery. If a headache is felt after laser, a pain reliever that does not have blood thinning properties can be taken. It is necessary to pay attention to the use of medication as recommended by the doctor. First day It is normal to have blurred vision and stinging, burning and watering in the eyes for 3-4 hours. The patient can leave our hospital after this control. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.The patient, whose laser treatment is completed, is kept waiting for about half an hour and is taken for a control examination. Pregnancy has a known effect on the stability of refractions and visual acuity. The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial. Evidence of macular pathology as per optical coherence tomography examination.Clinically significant or severe ocular surface disease that would affect study measurements based on the investigator's opinion.Down's Syndrome, Parkinson's Disease unable to fixate). Patients with physical or intellectual disability (e.g.Difficulties comprehending written or spoken English language.Expected post-op VA worse than 20/25 (Snellen).Evidence of keratoconus as per Pentacam.Ocular comorbidity that might hamper postoperative visual acuity.If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study. Planned cataract removal by femtosecond laser.Motivated for greater degree of spectacle independence vs monofocal IOL.Willing and able to comply with scheduled visits and other study procedures. ![]() Willing and able to provide written informed consent for participation in the study.Undergoing uncomplicated bilateral cataract surgery with IOL implantation.Note: Ocular criteria must be met in both eyes. Subjects are eligible for the study if they meet the following criteria: Why Should I Register and Submit Results?.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |